XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Distributions in Excess of Accumulated Earnings [Member]
Accumulated Other Comprehensive Loss, Net [Member]
Noncontrolling Interest [Member]
Issuance of common stock under:            
Cumulative effect upon adoption of ASU | ASU 2016-01 [Member]       $ 2,234    
Cumulative effect upon adoption of ASU | ASU 2017-05 [Member]       119,651    
Balance at period beginning at Dec. 31, 2017 $ 6,396,825 $ 7 $ 7,129,571 (833,726) $ (18,446) $ 119,419
Balances (in shares) at Dec. 31, 2017   66,054        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 96,639     90,918   5,721
Reversal of unrealized losses upon the sale of marketable debt securities (1)       (1) 0
Change in fair value of derivatives and amortization of swap settlements 6,254       6,046 208
Change in fair value of marketable debt securities, net (77)       (74) (3)
Issuance of common stock under:            
Stock option and restricted stock plans, net 1,222 $ 0 1,222      
Stock option and restricted stock plans, net (in shares)   7        
Sale of common stock, net (67)   (67)      
Equity based compensation costs 2,530   2,253     277
Retirement of common stock, net (3,774) $ 0 (3,774)      
Retirement of common stock, net (in shares)   (17)        
Changes in the redemption value of redeemable noncontrolling interest (1,953)   (1,957)     4
Distributions to noncontrolling interest (6,297)         (6,297)
Common stock dividends (122,850)     (122,850)    
Balance at period end at Mar. 31, 2018 6,492,159 $ 7 7,127,248 (743,773) (14,709) 123,386
Balances (in shares) at Mar. 31, 2018   66,044        
Issuance of common stock under:            
Cumulative effect upon adoption of ASU 181       175 6
Cumulative effect upon adoption of ASU | ASU 2016-01 [Member] 0       (2,234)  
Cumulative effect upon adoption of ASU | ASU 2017-05 [Member] 123,708         4,057
Balance at period beginning at Dec. 31, 2018 6,393,844 $ 7 7,093,079 (812,796) (13,217) 126,771
Balances (in shares) at Dec. 31, 2018   65,890        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 125,505     118,858   6,647
Reversal of unrealized losses upon the sale of marketable debt securities 33       32 1
Change in fair value of derivatives and amortization of swap settlements (1,993)       (1,926) (67)
Change in fair value of marketable debt securities, net 123       119 4
Issuance of common stock under:            
Stock option and restricted stock plans, net 3,204 $ 0 3,204      
Stock option and restricted stock plans, net (in shares)   51        
Sale of common stock, net (20)   (20)      
Equity based compensation costs 2,600   2,301     299
Retirement of common stock, net (56,989) $ 0 (56,989)      
Retirement of common stock, net (in shares)   (234)        
Changes in the redemption value of redeemable noncontrolling interest (1,767)   (3,027)     1,260
Distributions to noncontrolling interest (7,164)         (7,164)
Redemptions of noncontrolling interest (12,213)   (10,394)     (1,819)
Redemptions of noncontrolling interest (in shares)   9        
Common stock dividends (128,149)     (128,149)    
Balance at period end at Mar. 31, 2019 $ 6,317,195 $ 7 $ 7,028,154 $ (822,087) $ (14,817) $ 125,938
Balances (in shares) at Mar. 31, 2019   65,716